Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
23%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
IXJ
114
HOLDINGS
10%
ALSO IN CANC
CANC
50
HOLDINGS
22%
ALSO IN IXJ
SECTOR DRIFT (IXJ minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 7.3% | 3.6% | 3.6% |
 |
ASTRAZENECA PLC | 3.4% | 4.3% | 3.4% |
 |
NOVARTIS AG | 3.3% | 4.2% | 3.3% |
|
ABBVIE INC | 5.2% | 2.9% | 2.9% |
|
AMGEN INC | 2.3% | 2.4% | 2.3% |
IXJ Overweight Relative to CANC
|
JOHNSON & JOHNSON | 6.2% |
|
ELI LILLY & CO | 3.7% |
|
ABBOTT LABORATORIES | 3.5% |
|
UNITEDHEALTH GROUP INC | 3.4% |
|
ROCHE HOLDING LTD | 3.2% |
|
THERMO FISHER SCIENTIFIC INC | 2.6% |
|
INTUITIVE SURGICAL INC | 2.5% |
 |
NOVO NORDISK A/S-B | 2.4% |
|
ABBVIE INC | 2.3% |
|
BOSTON SCIENTIFIC CORP | 2.3% |
IXJ Underweight Relative to CANC
|
BRIDGEBIO PHARMA, INC. | -5.2% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.9% |
|
REVOLUTION MEDICINES, INC. | -4.8% |
 |
MERUS N.V. | -4.5% |
|
SUMMIT THERAPEUTICS INC | -4.2% |
|
GENMAB A/S SPONSORED ADR | -3.8% |
|
EXELIXIS INC | -3.4% |
|
ARCELLX, INC. | -3.3% |
|
NUVALENT, INC. CLASS A | -3.2% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -3.1% |